BOM Network Unveils Solutions to Tokenize Real-World Assets

Hong Kong – December 11, 2024 – (SeaPRwire) – Recently, BOM Network is proud to unveil its solutions to tokenize a wide range of real-world assets, from real estate to commodities, and use these tokens for trading, lending, or as collateral. Real-World Assets (RWA): The Bridge Between Traditional Finance and Blockchain Revolution In recent years, the crypto market has undergone remarkable growth, but its volatility and limited real-world use cases have often raised concerns. Real-World Assets (RWA) are emerging as a pivotal trend that may fundamentally reshape the blockchain and crypto space by creating a more stable and tangible connection to traditional finance. The tokenization of RWAs allows for real estate, commodities, and other physical assets to be represented on the blockchain, unlocking liquidity and expanding investment opportunities.RWAs bridge the gap between traditional assets and decentralized finance (DeFi), bringing stability, security, and trust into the often volatile crypto markets. This fusion offers several key benefits: Access to Illiquid Assets Increased Liquidity and Market Efficiency Global Access The Future of Banking and RWA Integration BOM Network is one standout project in the RWA space, focusing on integrating blockchain with traditional financial services. BOM Network’s unique approach lies in its emphasis on combining traditional banking services with the efficiency of blockchain, making it an attractive solution for institutions looking to bridge the gap between old and new financial systems. BOM Network has already established partnerships with global financial institutions, offering a scalable and secure way for investors to participate in the RWA market. Its platform is designed for both retail and institutional investors, making it a key player in the future of decentralized finance. By integrating RWAs into its ecosystem, BOM Network aims to drive the mainstream adoption of blockchain technology and create a more efficient, liquid, and globally accessible financial system. As the tokenization of RWAs gains traction, projects like BOM Network are leading the charge toward a more stable, diversified, and globally inclusive crypto market. About BOM Network BOM is the perfect bridge for capital from the real world to the Blockchain world. Meet a huge supply and demand of borrowing and lending from the real world into the cryptocurrency market. RWAs are likely to accelerate institutional adoption of blockchain technology. Moreover, the introduction of RWAs will catalyze regulatory development as governments and financial authorities adapt to this new intersection of traditional assets and blockchain technology. This convergence will bring crypto further into the mainstream, providing a fertile ground for innovation and growth. Social Links X: https://x.com/BOM_Network Telegram: https://t.me/BOMNetworkCommunity YouTube: https://www.youtube.com/@bom_network Media Contact Brand: BOM Network Contact: Media contact Email: support@bomnetwork.io Website: https://bomnetwork.io The article is provided by a third-party content provider. SeaPRwire ( https://www.seaprwire.com/ ) makes no warranties or representations in connection therewith. Sectors: Top Story, Corporate News SeaPRwire provides real time press release distribution for companies and organizations to 6,500+ media outlets & 3.5 million professional desktops in 90 regions. It distributes press releases in different languages, including: IndonesiaFolk, IndoNewswire, SEATribune, IDNewsZone, LiveBerita, DailyBerita, TaiwanPR, SinchewBusiness, AsiaEase, BuzzHongKong, SingapuraNow, TIHongKong, TaipeiCool, TWZip, AsiaFeatured, dePresseNow, THNewson, KULPR, VNFeatured, MENAEntry, HunaTimes, DubaiLite, ArabicDir, BeritaDaring, TekanAsia, JamKopi ...

BDO公布「2024年第六届BDO 环境、社会及管治大奖」得奖名单

香港, 2024年12月11日 - (亚太商讯 via SeaPRwire.com) - 全球第五大会计及咨询网络BDO公布第六届BDO环境、社会及管治大奖(「大奖」)得奖名单,获奖企业把ESG原则及对气候变化的考量融入业务策略,并透过推行具影响力及长远的可持续发展措施,积极强调ESG的重要并推动其发展。本年度BDO ESG大奖获上市公司大力支持,于提名阶段已录得逾110间公司参选,创六年新高。所有进入决赛的入围者均获邀出席颁奖典礼,亲身见证得奖名单诞生。(按此或见下列完整名单*)「碳中和」再度成为BDO 环境、社会及管治大奖2024的主题大奖,强调企业于减缓气候变化及塑造绿色未来所担当的重要角色。主题大奖致力表扬于「碳中和」方面体现最佳实践的上市公司,包括在减少碳排放量及计划和采取有关措施方面等。今年竞逐主题大奖的公司非常优秀,实力旗鼓相当,共有三间公司获此殊荣,打破往绩。立信德豪会计师事务所董事总经理林鸿恩先生表示:「BDO于2018年首次举办大奖,当时上市公司刚起步探索推行ESG,时至今日,我们乐见越来越多上市公司重视及实践ESG的长远发展。迄今,BDO 环境、社会及管治大奖获市场高度认可。BDO 作为可持续发展的倡导者,对于有越来越多香港上市公司重视ESG感到非常高兴。从评审过程中,我们观察到参选公司推行有关ESG的举措,质素较以往有所提升,而且更具前瞻性。随着ESG的重要性及影响力不断扩大,我们希望藉大奖与各业界一起持续提高香港的绿色水平,巩固我们作为绿色金融中心的地位。」立信德豪会计师事务所董事总经理江智蛟先生表示:「随着社会对可持续性和社会责任的关注不断增加,越来越多投资者和机构将ESG纳入其投资决策中,并倾向支持那些符合ESG准则的企业。企业透过实行ESG政策,能够建立良好的声誉,有助于提升业务的竞争力,吸引更多投资者。BDO作为这方面的专业,致力于不同领域为香港上市公司提供支持,例如协助他们进行ESG报告及风险管理,为他们提供各项有关提升ESG表现的建议等。我们希望大奖能唤起社会各持份者的ESG意识,未来可见到更多香港上市或非上市公司同样重视ESG的实践。」立信德豪会计师事务所董事兼风险咨询服务总监郑文汉表示:「今年获奖企业涵盖多个行业,所有获提名公司均在各个竞逐领域展示出超卓表现。BDO为一众致力在可持续发展方面努力不懈的得奖公司感到自豪,同时亦非常荣幸BDO能透过此奖项及我们的专业,支持所有为建立更环保和负责任商业环境而作出贡献的公司。」BDO 环境、社会及管治大奖 2024得奖者 (得奖者排名不分先后,以公司英文名称排序)ESG 最佳表现大奖 - 大型市值 中银香港(控股)有限公司 (02388.HK) 香港电讯信托与香港电讯有限公司 (06823.HK) 联想集团有限公司 (00992.HK)ESG 最佳表现大奖 - 中型市值 瑞声科技控股有限公司 (02018.HK) 嘉里建设有限公司 (00683.HK) 信义光能控股有限公司 (00968.HK)ESG 最佳表现大奖 - 小型市值 协合新能源集团有限公司 (00182.HK) 信德集团有限公司 (00242.HK) 越秀服务集团有限公司 (06626.HK)最佳 ESG 报告大奖 - 大型市值 香港电讯信托与香港电讯有限公司 (06823.HK) 中国生物制药有限公司 (01177.HK) 创科实业有限公司 (00669.HK)最佳 ESG 报告大奖 - 中型市值 嘉里建设有限公司 (00683.HK)电讯盈科有限公司 (00008.HK)信义光能控股有限公司 (00968.HK)最佳 ESG 报告大奖 - 小型市值 新世界百货中国有限公司 (00825.HK) 信义能源控股有限公司 (03868.HK) 越秀服务集团有限公司 (06626.HK)ESG 年度大奖 - 大型市值 香港电讯信托与香港电讯有限公司 (06823.HK)ESG 年度大奖 - 中型市值 嘉里建设有限公司 (00683.HK)ESG 年度大奖 - 小型市值 越秀服务集团有限公司 (06626.HK)ESG突出表现大奖 - H股公司 中国铁塔股份有限公司 (00788.HK) 上海电气集团股份有限公司 (02727.HK) 中兴通讯股份有限公司 (00763.HK)主题大奖 联想集团有限公司 (00992.HK) 越秀地产股份有限公司 (00123.HK) 中兴通讯股份有限公司 (00763.HK)圖片說明BDO及评审团代表出席2024年BDO环境、社会及管治大奖颁奖典礼。2024年BDO环境、社会及管治大奖各得奖公司、BDO及评审团合影。编辑垂注有关香港立信德豪会计师事务所有限公司 (BDO Limited)香港立信德豪会计师事务所有限公司是BDO会计师事务所国际网络的香港成员所。BDO国际网络遍布全球166个国家及地区,透过逾1,770多个办事处及超过115,600多名专业人员,在世界各地提供财务咨询服务。立信德豪自1981年在香港成立,致力透过全面的专业服务协助企业成长。专业服务包括审计服务、风险咨询服务、专项咨询服务及税务服务。有关详情,可参阅网站www.bdo.com.hk。查询联络卢瑞燕立信德豪市场部高级经理及部门主管香港刘玉娟立信德豪市场部高级经理香港纵横财经公关顾问有限公司李惠儿李希彤电话 +852 2218 3042手提 +852 9613 5175salalo@bdo.com.hk电话 +852 2218 2325手提 +852 9285 4151heidilau@bdo.com.hk电话 +852 2864 4834sprg_bdo@sprg.com.hk电话 +852 2864 4813sprg_bdo@sprg.com.hk  Copyright 2024 亚太商讯 via SeaPRwire.com.

Brawijaya University develops data system for climate change monitoring

MALANG, E. JAVA, Indonesia, Dec 11, 2024 - (ACN Newswire via SeaPRwire.com) - Brawijaya University collaborated with several international institutions to develop the Magnetic Data Acquisition System (MAGDAS) to monitor climate change globally and mitigate disasters in the future.Disaster mitigation and natural resource exploration expert from Brawijaya University, Prof. Sukir Maryanto, in the MAGDAS Cangar Station in East Java. (ANTARA/HO-Brawijaya University)Some institutions partaking in this initiative include the International Research Center for Space and Planetary Environmental Science (i-SPES) from Kyushu University in Japan, the National Research Institute of Astronomy and Geophysics (NRIAG) of Egypt, and several universities in Malaysia.Disaster mitigation and natural resource exploration expert from Brawijaya University, Prof. Sukir Maryanto, explained that one of the data system stations is located in the Volcano & Geothermal field laboratory in the Agro Techno Park Cangar Complex, Sumberbrantas Village, Batu City, East Java."It will be developed to mitigate tectonic and volcanic earthquake disasters," he noted in a statement on Thursday (Dec 5).Construction for the Cangar Station, which is the collaboration between BRAVO GRC, Brawijaya University, and i-SPES Kyushu University, began in March 2024.The installation of this data system involved a team from Kyushu University and two scientists from Egypt, with one acting as a researcher at i-SPES and the other a partner from the NRIAG in Egypt.Later, after becoming fully functional, the MAGDAS in Cangar Station will be integrated with a system network centered at Kyushu University, Japan, Prof. Sukir added."The construction of the MAGDAS station in Cangar has a significant impact on research and collaboration both at the national and international levels," he remarked.The plan is that in March 2025, an induction-based magnetometer sensor developed by Nagoya City University, Japan, will be installed on the recommendation of the MAGDAS host at Kyushu University.Currently, two new devices have been installed at Cangar Station, including the 3D Fluxgate Magnetometer from i-SPES Kyushu University and a seismic sensor from BRAVO GRC Brawijaya University.The seismic sensor functions to detect seismic waves that occur on Earth.Prof. Sukir expressed hope that these two parameters can be studied in an integrated manner at Cangar Station so that science can be developed to connect phenomena on Earth and in space."The new magnetometer sensor will be installed side by side with the existing MAGDAS and seismic sensors," he explained."Data from magnetic and seismic sensors need to be studied intensively because phenomena on the ground and phenomena in the air are not necessarily the same," he pointed out.Sukir also showed real-time recordings from MAGDAS in Cangar, which include data from Peru, Japan, the Philippines, and Malaysia, as well as various magnetic components with different variations.For more information, please click: https://ub.ac.idBrawijaya University: https://prasetya.ub.ac.id Editor: Yuni Arisandy Sinaga, Copyright (c) ANTARA 2024 Copyright 2024 ACN Newswire via SeaPRwire.com.

Everest Medicines: Accelerating Innovation in Renal Disease to Forge a Path Toward Biopharma Leadership

HONG KONG, Dec 11, 2024 - (ACN Newswire via SeaPRwire.com) – As reported by the South China Morning Post today, Everest Medicines (HKEX 1952.HK) is accelerating its journey to become a leading biopharmaceutical company in the Asia-Pacific region, driven by robust R&D capabilities and exceptional commercialization expertise.Breakthroughs in Renal Disease Innovation with EVER001On December 4, Everest Medicines announced positive results in preliminary analysis of Phase 1b/2a clinical trial of EVER001, its next-generation, globally owned covalent reversible Bruton’s Tyrosine Kinase (BTK) inhibitor. The trial focuses on primary membranous nephropathy (pMN), a common pathological type of nephrotic syndrome in adults with significant unmet medical needs. The prevalence of pMN in China has been increasing, making it the second most common cause of nephrotic syndrome after IgA nephropathy (IgAN). Currently, there are approximately 2 million patients with pMN in China, 80,000 to 100,000 in the United States, 80,000 in Europe, and 40,000 in Japan,with incidence rates rising in recent years, reflecting its growing global disease burden.Unlike traditional covalent irreversible BTK inhibitors, EVER001 employs a novel covalent reversible mechanism that combines strong target binding with excellent selectivity, significantly reducing off-target toxicity. Positive results in preliminary analysis revealed promising outcomes, with over 90% reductions in anti-PLA2R antibodies and substantial improvements in proteinuria. Additionally, patients in the low-dose cohort who have completed 36 weeks of treatment, 81.8% achieved overall clinical remission, and 91% achieved immunological complete remission. In the high dose cohort, 85.7% patients achieved overall clinical remission and all patients achieved immunological complete remission by week 24. With no currently approved treatments for pMN, EVER001 represents a potentially best-in-class therapeutic candidate. These results highlight EVER001’s potential to deliver best-in-class efficacy and safety, making it a promising treatment not only for pMN but also for a range of other autoimmune glomerular diseases, including lupus nephritis (LN), IgAN, Minimal Change Disease (MCD), and focal segmental glomerulosclerosis (FSGS).With broad indication potential, rising disease prevalence, and Everest Medicines’ global rights, EVER001 represents a high-value asset in a “Blue Ocean” area with significant commercial potential. Kidney disease therapeutics have become a hotspot for innovation and investment in recent years, attracting major multinational pharmaceutical companies. For example, Vertex Pharmaceuticals acquired Alpine Immune Sciences this April for $4.9 billion to access its kidney autoimmune disease therapies. Similarly, Novartis acquired Chinook Therapeutics in June 2023 for $3.5 billion, gaining access to two late-stage treatments for rare, severe chronic kidney diseases.Driving Commercial Success with a Dual-Engine StrategyEverest Medicines continues to strengthen its leadership in nephrology with NEFECON(R), the first FDA-approved treatment for IgAN and the first etiological therapy for IgAN in China. Its inclusion in the 2024 National Reimbursement Drug List (NRDL) marks a significant milestone, enhancing patient accessibility and driving market penetration starting January 1, 2025. Since its commercial launch in May 2024, NEFECON(R) has generated RMB167 million in sales within its first month. The product is also approved in Macau, Hong Kong, Taiwan, South Korea, and Singapore, further cementing Everest’s expertise in nephrology.Everest’s diversified portfolio also includes XERAVA(R) and VELSIPITY(R). XERAVA(R), a novel broad-spectrum antibiotic, demonstrated an overall effectiveness rate of 90.9% after three days of treatment in the "Comprehensive Evaluation Project on the Clinical Application of Eravacycline", contributing RMB134 million in revenue in H1 2024. VELSIPITY(R), approved under the "Hong Kong and Macau Medicine and Equipment Connect" policy, is now available in three designated medical institutions within the Greater Bay Area. It has also received approvals in Macau and Singapore, with an NDA accepted in Hong Kong and plans for an NDA submission in Mainland China by year-end.Everest is accelerating innovation through its proprietary mRNA platform, a cornerstone of its long-term R&D strategy. In August 2024, Everest launched an Investigator-Initiated Clinical Trial for EVM16, a personalized mRNA cancer vaccine, at Peking University Cancer Hospital and Fudan University Cancer Hospital. The company is also advancing mRNA-based in vivo CAR-T programs for cancer and autoimmune diseases, expanding its pipeline’s potential.As of now, Everest Medicines reached a 52-week high of HKD 49.7, closing at HKD 47.85. Since announcing its mid-year results, the stock price has more than doubled, reflecting strong investor confidence. With its dual-engine strategy, Everest has positioned itself as a rising leader in the global biopharmaceutical industry, focusing on unmet medical needs, particularly in renal diseases, and breakthrough therapies like EVER001. Supported by strong financial momentum and a clear vision, Everest is poised for sustainable growth and lasting value for patients and shareholders. Copyright 2024 ACN Newswire via SeaPRwire.com.

Eisai’s “URECE(R)” (Dotinurad) Approved in China for Gout Patients with Hyperuricemia

TOKYO, Dec 11, 2024 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. announced today that it has received approval for “URECE®” (brand name in China: “优乐思®”, generic name: dotinurad) from the National Medical Products Administration in China as a treatment for gout patients with hyperuricemia.This approval is based on the results of a multicenter, active-controlled, double-blind, parallel-group, randomized, Phase 3 study conducted by Eisai in China.1 In this study, 451 gout patients were randomized into either the dotinurad group or febuxostat group in a 1:1 ratio. The results of this study showed that the proportion of subjects with serum uric acid levels of 6.0 mg/dL or less at 24 weeks, which was the primary endpoint, was 73.6% [95% confidence interval (CI): 67.8, 79.5] in the dotinurad group and 38.1% [95% CI: 31.6, 44.5] in the febuxostat group, confirming the statistical superiority of dotinurad 4 mg over febuxostat 40 mg (difference of proportion 35.87% [95% CI: 27.36, 44.37, p<0.001]).The most common adverse events were gouty arthritis, COVID-19, and liver function abnormality in the dotinurad group, and gouty arthritis, COVID-19, and increased alanine aminotransferase (ALT) in the febuxostat group. No new safety concerns with dotinurad were observed.“URECE” is a new therapeutic medicine for gout and hyperuricemia discovered by FUJI YAKUHIN. It suppresses uric acid reabsorption and lowers blood uric acid levels by selectively inhibiting the urate transporter (URAT1) related to reabsorption of uric acid in the kidney. Eisai concluded a license agreement with FUJI YAKUHIN for China and five ASEAN member states: Indonesia, Malaysia, Myanmar, the Philippines, and Thailand, granting exclusive development and distribution rights in these countries. URECE was approved in Thailand for gout and hyperuicemia in September, 2024. In Japan, FUJI YAKUHIN obtained manufacturing and marketing approval for URECE in January 2020 and launched it in May 2020.It is estimated that there are currently about 16 million patients with gout in China.2 It is expected that the number of patients will further increase in the near future due to changes in lifestyle and dietary preferences in accordance with socioeconomic development.Eisai is committed to providing “URECE” to more patients with gout in China, including through its inclusion in the National Reimbursement Drug List (NRDL), and will contribute to improving the quality of life (QOL) of patients.“优乐思®” Product OutlineChinese Trade name: “优乐思” (URECE)Chinese generic name: 多替诺雷片 (Dotinurad Tablets)Indication for use: It is indicated for gout patients with hyperuricemia.Dosage and administration: For oral use, the usual adult initial dosage is 1 mg of dotinurad once daily. The dose level should then be gradually increased as needed by checking blood uric acid levels. The usual maintenance dosage is 2 mg once daily and may be adjusted according to the patient’s condition, but up to 4 mg once daily.About “URECE®” (Dotinurad)URECE is a therapeutic medicine for gout and hyperuricemia discovered by FUJI YAKUHIN. URECE selectively inhibits URAT1, one of the uric acid transporters, thus preventing reabsorption of uric acid by the kidneys and promoting uric acid excretion in the urine. In addition, URECE has a small effect on other transporters affecting uric acid secretion, so it reduces serum uric acid levels at lower doses. URECE is expected to have a low risk of side effects and drug interactions.In Japan, FUJI YAKUHIN obtained manufacturing and marketing approval for URECE in January 2020 and launched it in May 2020.About the Phase 3 Clinical Trial (Study FYU-981-J086-301)1This was a multicenter, active-controlled, double-blind, parallel-group, randomized, Phase 3 study conducted to confirm the superiority of dotinurad 4mg over febuxostat 40mg as the primary evaluation, assess safety, and confirm the non- inferiority of dotinurad 2mg to febuxostat 40mg as the secondary evaluation in Chinese patients with gout.Patients with gout and serum uric acid (SUA) levels exceeding 7.0 mg/dL were randomly assigned to either the dotinurad group or the febuxostat group in a 1:1 ratio, investigational product treatment for 24 weeks (the dotinurad group received 1mg/day for 4 weeks, 2mg/day for 8 weeks, and 4mg/day for 12 weeks, while the febuxostat group received 20mg/day for 4 weeks and 40mg/day for 20 weeks). The primary endpoint was the proportion of patients with SUA ≤6.0mg/dL at 24 weeks, and the secondary endpoint was the proportion of patients with SUA ≤6.0mg/dL at 12 weeks.Of the total 451 patients, 225 were assigned to the dotinurad group and 226 to the febuxostat group. Of these, 441 patients (220 in the dotinurad group and 221 in the febuxostat group) were included in the Full Analysis Set (FAS).For the primary endpoint, the proportion of patients with SUA ≤6.0mg/dL at 24 weeks was 73.6% [95% confidence interval (CI): 67.8, 79.5] in the dotinurad group and 38.1% [95% CI: 31.6, 44.5] in the febuxostat group, confirming the statistical superiority of dotinurad 4mg over febuxostat 40mg (difference of proportion 35.87% [95% CI: 27.36, 44.37, p<0.001]).For the secondary endpoint, the proportion of patients with SUA ≤6.0mg/dL at 12 weeks was 55.5% in the dotinurad group and 50.5% in the febuxostat group, confirming the statistical non-inferiority of dotinurad 2mg to febuxostat 40mg (difference of proportion 5.24% [95% CI: -3.69, 14.17]).The most common adverse events were gouty arthritis, COVID-19, and liver function abnormality in the dotinurad group, and gouty arthritis, COVID-19, and increased alanine aminotransferase (ALT) in the febuxostat group. No new safety concerns with dotinurad were observed.(1) Sun J, Wang Y, Zhang X, et al. POS0255 A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PHASE 3 STUDY COMPARING EFFICACY OF DOTINURAD AND FEBUXOSTAT FOR THE TREATMENT OF GOUT IN CHINESE SUBJECTS. Annals of the Rheumatic Diseases 2024;83:407-408.(2) For the estimated data regarding the number of patients with gout: Data of morbidity prevalence rate - Rui Liu et al., Prevalence of Hyperuricemia and Gout in Mainland China from 2000 to 2014: A Systematic Review and Meta-Analysis, BioMed Research International, Volume 2015, Article ID 762820Estimated data calculated from United Nations World Population Estimates - World Population Prospects, URL:https://population.un.org/wpp/ Media Inquiries:Eisai Co., Ltd.Public Relations Department TEL: +81-(0)3-3817-5120 Copyright 2024 JCN Newswire via SeaPRwire.com.

云顶新耀:加速肾病领域创新 迈向全球生物制药领先地位

香港, 2024年12月11日 - (亚太商讯 via SeaPRwire.com) - 据《南华早报》报道,云顶新耀(HKEX 1952.HK)正加速实现其成为亚太地区领先生物制药企业的愿景。公司凭借强大的研发实力与卓越的商业化能力,在持续推动业务发展的同时,不断深化在全球生物制药领域的布局。近期,云顶新耀在核心商业化产品和突破性研究方面取得了一系列重要的里程碑式进展,充分体现了其在为亚洲乃至全球患者提供创新治疗解决方案方面的坚定承诺与卓越能力。这些成就不仅巩固了公司在行业中的领先地位,也进一步彰显了其致力于满足未被满足医疗需求的长期战略愿景。EVER001:肾病创新领域的突破2024年12月4日,云顶新耀宣布其自主研发且拥有全球权益的新一代共价可逆布鲁顿酪氨酸激酶(BTK)抑制剂EVER001,在1b/2a期临床试验阶段性数据中取得积极结果。本次试验聚焦原发性膜性肾病(pMN),是成人原发性肾病综合征的主要原因,存在未被满足的医疗需求。近年来,中国pMN的发病率持续上升,成为继IgA肾病(IgAN)后的第二大肾病综合征常见的病理类型。目前,中国约200万原发性膜性肾病患者,而在美国约有8万-10万患者,欧洲约8万患者,日本约4万患者,疾病负担在全球范围内日益加重,且目前全球没有获批此适应症的药物。不同于传统的共价不可逆BTK抑制剂,EVER001采用独特的共价可逆机制,结合其强大的靶点结合力与良好的安全性特征,避免持续抑制带来的毒副作用。试验结果显示,抗-PLA2R自身抗体水平在数据截止日期时已达到接近100%的下降,而早在低剂量组的24周和高剂量组的12周,抗-PLA2R自身抗体下降已超过90%。此外,在已完成36周治疗的低剂量组患者中,81.8%的患者实现临床缓解,高剂量组中已完成24周治疗的患者已有85.7%实现临床缓解。除低剂量组的1例患者外,其他所有完成36周治疗的低剂量组患者,以及所有经24周治疗的高剂量组患者分别在36周和24周都实现了免疫学完全缓解。EVER001作为一款潜在的同类最佳产品,该结果不仅显示了EVER001在pMN治疗中的高选择性、优异的药代动力学特征、良好的安全性特征以及强大的靶点结合力,还凸显了其在其他自身免疫性肾病,如狼疮性肾炎(LN)、IgA肾病、微小病变病(MCD)和局部节段性肾小球硬化(FSGS)中的广阔适应症前景。凭借广泛的适应症前景、日益增加的疾病发病率以及全球范围内的开发权益,EVER001成为具有显著商业价值的"蓝海"资产。近年来,肾病治疗领域已成为医药创新与资本投资的热点,吸引了众多跨国制药巨头的目光。以2023年为例,Vertex Pharmaceuticals斥资49亿美元收购了Alpine Immune Sciences,以获取其针对肾脏自身免疫性疾病的先进疗法。同年,诺华(Novartis)以35亿美元收购了Chinook Therapeutics,从而获得两项处于后期开发阶段的罕见肾病治疗药物。这些交易不仅凸显了全球医药行业对肾病领域的重视,也进一步验证了该领域创新治疗方案的巨大潜力和市场价值。"双轮驱动"战略推动商业化成功云顶新耀通过核心产品耐赋康(R)进一步巩固了其在肾病治疗领域的领导地位。耐赋康(R)是全球首个获得FDA批准的IgA肾病(IgAN)对因治疗药物,同时也是中国首个获得IgA肾病适应症的对因治疗药物。该药物已成功纳入2024年国家医保药品目录,这一里程碑不仅显著提升了患者可及性,还将大幅推动市场渗透率,其相关政策将于2025年1月1日正式实施。自2024年5月在中国大陆商业化上市以来,仅一个月耐赋康(R)销售额即突破人民币1.673亿元。此外,该药物还在中国澳门、中国香港、中国台湾、韩国及新加坡获批,进一步彰显了云顶新耀在全球肾病领域的专业实力与市场影响力。云顶新耀的多元化产品组合还包括氟环素类抗菌药物依嘉(R)与自身免疫疾病治疗药物伊曲莫德(VELSIPITY(R))。依嘉(R)作为全球首个氟环素类抗菌药物,在国家卫生健康委抗菌药物临床应用与耐药评价专家委员会发起并主办的"依拉环素临床应用综合评价项目"中表现卓越,临床疗效分析显示,依拉环素治疗3天时的整体有效率为91.1%,治疗结束时整体有效率为90.1%。截至2024年上半年,依嘉(R)累计销售额已达到2.33亿元,充分体现了市场对其的高度认可和接受度。在自身免疫疾病领域,伊曲莫德(VELSIPITY(R))的商业化进程取得重要进展。该产品已在中国澳门和新加坡获批上市,并通过"港澳药械通"政策率先进入粤港澳大湾区,成为云顶新耀第三款商业化产品。近期,伊曲莫德的新药上市许可申请已在中国香港获正式受理,公司计划于今年底向中国大陆递交申请,进一步释放其市场潜力。在研发领域,经过临床验证的mRNA技术平台是公司自主研发的核心部分,公司将自主研发重点转向拥有全部知识产权和全球权益的mRNA肿瘤治疗性疫苗。作为公司长期研发战略的重要支柱,该平台已实现显著突破。2024年8月,云顶新耀启动一款个性化肿瘤疫苗EVM16的研究者发起的临床试验项目(IIT),该研究由北京大学肿瘤医院和复旦大学附属肿瘤医院发起。此外,公司还在积极推进基于mRNA的体内CAR-T项目,用于癌症和自身免疫性疾病的治疗,不断拓展其研发管线的潜在应用。本周一,云顶新耀股价创下52周新高,盘中最高达49.7港元,收盘47.85港元。自中期业绩公布以来,股价已实现翻倍,充分体现了市场对公司未来发展的强烈信心。通过"双轮驱动"战略,云顶新耀持续聚焦未被满足的医疗需求,尤其在肾病等关键领域表现出色,并以EVER001等突破性疗法推动业务增长。凭借强劲的财务势头和清晰的战略规划,云顶新耀正稳步迈向可持续增长,为患者和股东创造长期价值。 Copyright 2024 亚太商讯 via SeaPRwire.com.

Provision of the First Template Function Adapted to the IFRS Sustainability Disclosure Standards in Japan (IFRS S1 and S2) on the Sustainable Finance Platform

TOKYO, Dec 10, 2024 - (JCN Newswire via SeaPRwire.com) - The Association for Promotion of Sustainable Finance Platform (AP-SFPF) and Hitachi, Ltd. (Hitachi) today announced that we will begin providing the first template feature adapted to the IFRS sustainability disclosure standards in Japan (IFRS S1 and S2*1) formulated by the International Sustainability Standards Board (ISSB), on the Sustainable Finance Platform - Engagement Support Service (SFP-ESS), a digital platform that promotes ESG investing by establishing seamless connections between asset management companies and listed companies.Specifically, Hitachi's SFP-ESS, developed under license from the IFRS Foundation, will be enhanced with a templatedesigned to facilitate reporting in accordance with IFRS S1 and S2 and the SASB Standards*2 (Templates). AP-SFPF will offer the Templates to asset management companies and listed companies in Japan as the service provider.By starting to provide the Templates, AP-SFPF and Hitachi will support listed companies in Japan in their disclosure of information in conformance with IFRS S1 and S2 and communication between listed companies and assetmanagement companies. This will enable global institutional investors to properly evaluate sustainability-conscious corporate activities in the ESG perspective and contribute to the enhancement of the companies' corporate value.AP-SFPF is a general incorporated association that was established to connect diverse stakeholders andpromote effective and efficient communication, solving issues and considering projects to contribute to the continued development of the ESG market. It was established in July 2023 by eight companies, which mainly include financial institutions: MS&AD Insurance Group Holdings, Inc., Sompo Japan Insurance Inc., Tokio Marine & Nichido Fire Insurance Co., Ltd., Nippon Life Insurance Company, Hitachi, Ltd., Mizuho Bank, Ltd., Sumitomo Mitsui Banking Corporation, and MUFG Bank, Ltd.Background of the start to adapt the SFP-ESS for IFRS S1 and S2Recently, investors' interest in companies' sustainability initiatives has been growing and companies are implementing sustainability initiatives and disclosing information about them. However, there are various disclosure standards in Japan and global. This has created an issue regarding disclosures. The people in charge of disclosing information,especially people at listed companies engaging in business globally, are not sure which standards to refer to and unable to determine investors' expectations regarding the disclosure of information, in addition to being short of resources. To solve this situation, the ISSB announced IFRS S1 and S2 in June 2023 as global baseline standards forthe disclosure of sustainability-related information.In Japan, the Sustainability Standards Board of Japan (SSBJ) is formulating the Japanese version of S1 and S2 (the SSBJ standards), which are made to comply with all of the requirements of IFRS S1 and S2, the standards fordisclosing sustainability-related informationin Japan. The finalized standards are planned to be published by March 2025. In addition, the Financial ServicesAgency made it mandatory to disclose sustainability-related information in securities reports in the fiscal year ended March 31, 2023. It is also considering the gradual application of the SSBJ standards to companies listed on the PrimeMarket starting in the fiscal year ending March 31, 2027. Therefore, listed companies are facing urgent tasks, such asthe collection of sustainability-related information and the development of a disclosure process in line with IFRS S1and S2, to prepare for the disclosure of information becoming mandatory in the future and to enhance their corporate value.In response, AP-SFPF exchanged opinions with more than 100 companies, including asset management companiesand listed companies, and began to offer a beta version of the SFP- ESS and verify its value in October 2023 to reduce the workload of the people at listed companies in charge of disclosing information and promote ESG investingin Japan. By using the Templates to adapt the SFP-ESS to IFRS S1 and S2, AP-SFPF and Hitachi will help listed companies smoothly disclose ESG information and contribute to improving their corporate value.Outline of SFP-ESSThe SFP-ESS is a two-sided platform on which asset management companies and listed companies making ESG investments are connected seamlessly to deepen their mutual understanding of each other. Asset managementcompanies present their needs regarding the ESG information it expected that listed companies disclose in line with theSASB*2 Standards. Listed companies refer to this registered information, which enables them to understand the needs of asset management companies and use the information when formulating their disclosure policies.Listed companies enter their data into the platform and send it, publishing it alongside comments by following the disclosure items in the Templates. This facilitates asset management companies' side-by-side comparison of listedcompanies as the viewers and also enables them to understand data, including the details.Features of the Templates adapted to IFRS S1 and S2Regarding IFRS S1 and S2, documents explaining the disclosure standards themselves, the IFRS Sustainability Disclosure Taxonomy*3, and support materials including a guide for the voluntary application of ISSB Standards havebeen published. However, Japanese documents are limited, and each company is left to decide how they will disclose the information they should disclose in their integrated reports and other reports. To support the practical tasks done by these listed companies, the Templates come with an input interface available in Japanese, so that digital data can be entered and saved on the platform in accordance with definitions in the taxonomy. Specifically, the Templates helplisted companies understand and respond to IFRS S1 and S2 using the following three features.1. Disclosure items classified into three categories (major categories, intermediate categories, and subcategories)The IFRS Sustainability Disclosure Taxonomy information is classified in detail into four core classifications (governance, strategy, risk management, and metrics and targets). However, the hierarchical structure differs from item to item. In response, a creative measure was devised to streamline data entry by the people in charge ofthe disclosure of information at listed companies by classifying the information into major categories,intermediate categories and subcategories visualizing the hierarchical structure of the information. This helps the people in charge of disclosing information at companies understand information collection based on the definitions in IFRS S1 and S2 without difficulty.2. Supplementary information from the IFRS Foundation regarding each disclosure item is provided when viewing the Templates.The IFRS Foundation, provides application guidance which companies may want to refer to when entering information into the Templates.3. Tables styles and options enabling an intuitive understanding of the information that needs to be disclosed are availableOptimal table styles are provided on an item-by-item basis to enable people to intuitively understand and enter the information required for each disclosure item. For example, there is an appropriate answer space for itemsthat are yes or no questions. In addition, for items which require that risks be described, there is a multiple-choice section about the type of risk (physical or transition) and the time frame (short, medium, or long term), in addition to the space for describing the risk. This prevent the omission of information or the provision of insufficient information.Future developmentMoving forward, AP-SFPF and Hitachi will broadly expand the SFP-ESS with the Templates to listed companies andtalk with multiple listed companies preparing to comply with IFRS S1 and S2 ahead of others. It will thus collect opinionsand requests regarding the improvement of the convenience of the Templates and develop the Templates so that we are more useful and adapted to IFRS S1 and S2.We will also work to functionally enhance the SFP-ESS in addition to developing the Templates. Specifically, they moveforward with consideration and development to provide service features which will be needed in the promotion ofthe disclosure of information, dialogue, and engagement between asset management companies and listedcompanies, such as a feature enabling asset management companies to register their information disclosure needs, and to release these features one by one. We also plan to incorporate the finalized SSBJ standards which will be published by the SSBJ by March 2025.Speaking at Director of Earned Revenue, IFRS Sustainability, Eli Reisman, said:“The IFRS Foundation welcomes Hitachi as a licensee of its standards. The IFRS Foundation encourages companiesvoluntarily applying IFRS S1 and IFRS S2, in addition to the progress being made towards regulatory adoption or other use of IFRS S1 and IFRS S2 happening in 25+ jurisdictions globally. In order to facilitate this corporate disclosure, it’s imperative that various services and tools integrate the ISSB standards to support this process."Yasuki Imai, Vice President and Executive Officer, Head of Digital Systems & Services APAC Business, and CEO of Financial Institutions Business Unit, Hitachi, Ltd, said:“In line with this approach to sustainability reporting, Hitachi and its only reseller of SFP-ESS, The Association forPromotion of Sustainable Finance Platform, aim to facilitate the application of IFRS S1, S2, and SASB standards and provide guidance on industry-specific disclosures through the SFP-ESS platform: SFP-ESS is a digital platformdesigned to support companies in their sustainability reporting efforts. This tool is intended to assist companies in navigating the reporting process, with the goal of enhancing the standardization and relevance of ESG reporting.”AP-SFPF member company, Managing Executive Officer, Group Chief Sustainability Officer (CSuO), MS&AD Insurance Group Holdings, Inc., Naomi Motojima said:“MS&AD Insurance Group Holdings, Inc. engages in investment, lending and insurance underwriting activities in consideration with ESG as a signatory to Principles for Sustainable Insurance (PSI) and the Principles for ResponsibleInvestment (PRI). We consider “Symbiosis with global environment ~Planetary Health~” as an important issue forMS&AD group, and we are working on realizing “Action on climate change” and “Improvement of sustainability of natural capital” comprehensively to enhance the resilience of society. We help to solve ESG issues including climate change through insurance underwriting, investment and lending, and of course we also work to reduce our own Greenhouse gas (GHG) emissions. We regard them as missions that we have as an insurance and financing serviceprovider. SFP-ESS is a platform that increases the mutual understanding of companies and financial institutions regarding ESG information disclosure. We hope that using the disclosure templates adapted to S1 and S2, which will be newly implemented, will facilitate the disclosure of information related to companies' ESG activities and lead to investors appropriately evaluating the companies. Further, from the standpoint of an investor, we find the developmentof a platform which enables users to compare the information disclosed by companies using a same index beneficial in the activities for the appropriate evaluation of the activities of the companies. Therefore, we welcome the release of the template feature.”*1 Disclosure standards announced by the IFRS Foundation in June 2023. The standards consist of IFRS S1 (General Requirements for Disclosure of Sustainability-related Financial Information) and IFRS S2 (Climate-related Disclosures).*2 The Sustainability Accounting Standards Board (SASB) Standards provide industry-specific ESG disclosure guidance focused on financial materiality. As of August 2022, the International Sustainability Standards Board (ISSB) of the IFRS Foundation assumed responsibility for the SASB Standards.*3 The IFRS Sustainability Disclosure Taxonomy is a framework for digitally tagging sustainability-related financial disclosures Its goal is to digitalize informationand facilitate investors' and stakeholders' comparison and assessment of companies' sustainability performanceSFP-ESS websitehttps://sfp-ess.org/en/service/About the Association for Promotion of Sustainable Finance Platform (AP-SFPF)The AP-SFPF was established in July 2023 to solve issues and consider projects, with financial institutions playing a leading role, to create new value and contribute to the continued development of the ESG market, eventually resultingin the sustainable development of society through the connection of various stakeholders to each other and the provision of a platform which will facilitate efficient and effective communication related to ESG issues.Member companies: MS&AD Insurance Group Holdings, Inc., Sompo Japan Insurance Inc., Tokio Marine & NichidoFire Insurance Co., Ltd., Nippon Life Insurance Company., Hitachi, Ltd., Mizuho Bank, Ltd., Sumitomo Mitsui Banking Corporation., MUFG Bank, Ltd.Representative: Yoshihiro Kanaoka, Representative Director Location: 1-6-1 Marunouchi,Chiyoda-ku, Tokyo 100-8220, Japan Corporate website: https://sfp-ess.org/en/About Hitachi, Ltd.Hitachi drives Social Innovation Business, creating a sustainable society through the use of data and technology. We solve customers' and society's challenges with Lumada solutions leveraging IT, OT (Operational Technology) and products. Hitachi operates under the 3 business sectors of “Digital Systems & Services” – supporting our customers’ digital transformation; “Green Energy & Mobility” – contributing to a decarbonized society through energy and railway systems, and “Connective Industries” – connecting products through digital technology to provide solutions in various industries. Driven by Digital, Green, and Innovation, we aim for growth through co-creation with our customers. The company’s revenues as 3 sectors for fiscal year 2023 (ended March 31, 2024) totaled 8,564.3 billion yen, with 573 consolidated subsidiaries and approximately 270,000 employees worldwide. For more information on Hitachi, please visit the company's website at www.hitachi.com. Copyright 2024 JCN Newswire via SeaPRwire.com.

[Macao Products Receiving Wide Acclaim] Macao Companies Achieved Remarkable Success with Doubled Sales and Over 50 Business Matching Negotiations at the Singapore Food Expo

The four-day “Asia Pacific Food Expo 2024” successfully concluded on Monday (Dec 9th), with over 50 business matching negotiations taking place at the Macao Pavilion. Macao exhibitors are satisfied with the outcomes, as “Made in Macao” and “Macao Brand” products have garnered substantial repurchases and inquiries. “Sales figures for a single day at the event surpass those typically seen in Macao on weekdays”. The heightened demand at the event has elevated the popularity of Macao products to a peak, establishing them as the preferred choice among Singaporean and international businessmen. Moreover, some exhibitors have successfully connected with the local supermarkets and food agents through interactions. Furthermore, some businessmen have shown optimism regarding Macao’s business environment and the significant potential of Halal catering market in general. They engaged in profound discussions with Macao enterprises on-site and expressed their intentions to establish a presence in Macao. In Singapore, Ms. Elaine Wong, Member of Board of Directors of Macao Commerce and Investment Promotion Institute (IPIM), met with Honorary President Edward Liu and Executive Director Jan Tan of the Asian Federation of Exhibition and Convention Associations (AFECA) to promote the MICE advantages of Macao and Hengqin, and invited AFECA to hold conventions and exhibitions in Macao and Hengqin. Mr. Edward Liu expressed his intention to visit Macao and Hengqin for an inspection tour in 2025. Established in Singapore in 2005, AFECA currently has about 155 members, which are mainly the MICE industry associations in Asia. The “Consumption + Negotiation” Integrated Exhibition Aids Enterprises in Connecting with International Business Opportunities Organised by the Singapore Food Manufacturers’ Association, the “Asia Pacific Food Expo 2024” has an exhibition area of about 10,000 square meters. The event has drawn the participation of over 200 exhibitors from mainland China and Singapore, encompassing upstream, midstream and downstream industrial chain enterprises in the food and beverage industries. IPIM and the Industrial Association of Macau set up the Macao Pavilion, for the first time, at the “Asia Pacific Food Expo”, and organised the participation of 24 Macao SMEs and over 250 “Made in Macao”, “Macao Brand” products, of which nearly 80% were Halal-certified products or the distinguished “M Brand” quality products. Throughout the four-day event, Macao exhibitors, and the buyers and visitors from around the globe all benefited significantly. According to the Macao enterprises, the diverse customer sources of the Expo enable them to swiftly comprehend and access the latest market trends, and to grasp the new consumption patterns of international customers. Furthermore, the “consumption + negotiation” integrated exhibition can function as a platform for testing the products and establishing business networks. Local Internet influencers were also invited to promote Macao companies’ brands and their charms at the Macao Pavilion. Leveraging Insights from the Global Halal Food Sector to Craft the Golden Business Card for Halal Food in Macao At the event, exhibitors were delighted to witness the positive reception of Macao’s halal food by the visitors. Through the exhibition, they have recognised significant business prospects in Singapore and other halal food markets. They will leverage insights from the Singapore’s Halal food to upgrade Macao’s halal food production, in order to further enrich the experience of international visitors to Macao, thereby crafting Macao’s golden business card. Some visitors praised the layout and arrangement of the Macao Pavilion, which could let them fully feel the charm of Macao and quickly grasp the latest business information of Macao and Hengqin. The accurate connection with Macao enterprises for “one-on-one” negotiations also strengthened their intention to invest in Macao and Hengqin.

【澳门产品广获好评】澳企在新加坡参展喜获双收 销量翻倍促逾50场配对洽谈

一连四天的“亚太国际食品展2024”于今(9)日圆满闭幕。澳门馆内促逾50场配对洽谈,展商们满意成效,“澳门制造”、“澳门品牌”的产品获得高回购及高查询,“单日货品销量至少是澳门平日的翻倍”,连日热销让澳门产品的知名度推至高点,成为新加坡以至国际客商的“心头好”;亦有展商成功连线当地商超、代理商等。此外,有与会客商看好澳门营商环境以及清真市场发展潜力庞大,即场与澳门企业开展深入交流,并有落户澳门计划。 赴新加坡期间,澳门特别行政区招商投资促进局委员黄伊琳会面亚洲展览会议协会联盟(AFECA)Honorary President Edward Liu及Executive Director Jan Tan,推介澳琴会展优势,亦诚邀该会赴澳琴办展办会。Edward Liu透露2025年有计划赴澳琴考察。AFECA于2005年在新加坡成立,现有会员单位约155个,主要来自亚洲地区的会展行业协会。 “消费+洽商”一体展会助企业联通国际商机 “亚太国际食品展2024”由新加坡食品厂商联合会主办,展览面积约一万平方米,吸引来自中国内地、新加坡等逾200家展商参与,涵盖食品及饮料等行业的上中下游产业链企业。招商投资促进局联同澳门厂商联合会首次设置澳门馆,组织24家澳门中小企展销展示250多款“澳门制造”、“澳门品牌”产品,当中近80%澳门展商产品持清真认证或及“M唛”澳门产品优质认证。   四天展会澳门展商及世界各地与会客商均收获满满。有澳门企业代表指该展会客源多样,有助快速了解及获取市场最新动态,掌握客群的新型消费模式,而且展会集消费及洽商为一体,成为企业视作产品“试水”和建立商业网络的绝佳平台。澳门馆内还安排了当地的网络达人穿梭走访展位,助企业宣传推广品牌及产品魅力。 取经各地清真食品之长打造澳门清真食品新名片 同时展商喜见澳门清真食品获得不少客商好评,通过实地参展,了解到新加坡等清真食品市场商机巨大,会借镜新加坡清真等食品优点,融入到澳门清真食品升级箇中“内涵”,进一步满足并丰富国际客商的游澳体验,继而“升呢”成为澳门新名片。 有与会客商点赞展馆布局及安排到位,充分感受到澳门魅力的同时,亦能快速掌握澳琴最新营商信息,并叠加精准对接澳门企业开展“一对一”洽谈,加强了在澳琴投资的意欲。

顺丰控股进军港股 书写国际化发展新篇章

香港, 2024年12月10日 - (亚太商讯 via SeaPRwire.com) - 据经济日报报道,随着全球企业供应链的重塑、中国企业出海以及跨境电商的推动,市场对更高效、更灵活、更综合的物流服务的需求不断攀升。顺丰控股股份有限公司(「顺丰控股」,股份代号:6936.HK)以其独特的业务模式和强大的网络优势,积极布局国际物流服务,投身于时代革新发展的浪潮中。根据弗若斯特沙利文,按2023年收入计,顺丰控股是中国及亚洲最大的综合物流服务提供商,也是全球第四大综合物流服务提供商,仅次于联合包裹服务公司(UPS)、敦豪(DHL)和联邦快递(FedEx)。公开资料显示,顺丰控股连续多年位居《财富》世界500强企业之列。2024年,公司获评《财富》最受赞赏的中国公司第二位,且连续8年上榜「《财富》最受赞赏的中国公司」。11月27日,顺丰控股登陆港交所,掀开国际化发展新篇章。夯实物流基础网络 持续迎来盈利兑现顺丰控股最早于2010年即开始运营国际业务,主要服务中国客户的出境物流需求。如今,随着中国企业出海,国际供应链蕴含着重大转型机遇。2021年,公司携手嘉里物流,进一步强化了在东南亚的本土及跨境快递、国际供应链和国际货代能力。通过与嘉里物流的融通,其国际综合物流能力和客户基础得到进一步强化,为实现国际拓展的战略和愿景提供了重要助力。根据弗若斯特沙利文报告,按国际收入计,2023年顺丰的国际业务规模已在所有亚洲综合物流服务提供商中排名第一。值得关注的是,经过多年投入后,顺丰控股已度过资本开支的高峰期,迎来更高质量增长周期。一方面,业务规模扩张持续摊薄基础设施边际成本,提升其营业利润率。另一方面,公司新业务陆续进入"收获期",提供公司盈利弹性。具体而言,经济产品体系升级,助力利润稳步增长;大件业务于2022年净利润转盈,2023年在降本提效作用下盈利能力持续增厚;同城业务于2023年首次实现全年盈利,2024年延续高增长。得益于此,顺丰控股盈利能力持续增强,2024年前三季度,其收入同比增加9.4%,净利润同比增加28.0%。净利率达到3.7%,同比提升了0.5个百分点。未来,在上述因素的共同推动下,公司盈利能力有望进一步增强。加速推进国际业务 打开中长期成长空间对于顺丰控股而言,从亚洲到全球,是其发展的必然。为此,公司积极参与建设鄂州货运枢纽,作为亚洲第一、全球第四座以货运为主的物流枢纽,鄂州货运枢纽的投产将进一步扩大公司与同业在配送时效以及网络方面的差异化优势,促进公司降本增效,为国际业务拓展奠定了坚实的基础。随着位于鄂州货运枢纽的分拣及转运中心投入运营,凭借丰富的产品组合、综合的全球能力、并购经验、卓越的运营及精益的成本管控,顺丰控股能够有效整合市场并把握国内外的市场机遇。顺丰控股高管曾表示,赴港上市是出于国际化的长远考虑,最主要目的是利用全球化资本,实现规模快速扩张。本次上市,顺丰控股计划将募集资金的45%用于加强其国际及跨境物流能力,此将进一步提升公司国际产品的广度及深度,助力公司国际业务加速拓展。同时,H股上市也有助于提升公司品牌影响力及市场竞争力。在丰富的物流网络、领先的成本优势和综合物流能力的支撑下,顺丰控股有望抢占更大的全球市场份额,推动公司投资价值的不断增长。 Copyright 2024 亚太商讯 via SeaPRwire.com.

Combating customer harassment: Fujitsu, Toyo University and Kokoro Balance Research Institute launch field trial on AI-powered training program

TOKYO, Dec 11, 2024 - (JCN Newswire via SeaPRwire.com) - Fujitsu Limited, Toyo University Incorporated Educational Institution (Toyo University) and Kokoro Balance Research Institute today announced the commencement of a field trial on December 3, 2024, to develop a Training Program for Coping with Customer Aggression. This program leverages AI and incorporates insights from criminal psychology and mental health to tackle the growing societal issue of customer harassment, i.e., unreasonable or abusive behavior directed at staff by customers and clients.The program utilizes the “AI Tool for Experiencing Customer Aggression” developed using Fujitsu's generative AI technology, behavior change support technologies and Toyo University's expertise in criminal psychology. Fujitsu’s AI tool provides interactive feedback through the use of AI avatars and clarifies actions that can be taken to enhance participants' customer harassment response skills. To evaluate the program's effectiveness, Kokoro Balance Research Institute will leverage its mental health expertise to develop new psychological scales measuring customer service skills, stress management, and overall customer harassment response capabilities. Furthermore, the research partners will carry out a field trial with call center employees at Fujitsu Communication Services Limited (CSL), analyzing changes in participants' customer service skills, stress management, engagement, and subjective productivity to ensure the program's scientific validity.The full program is targeted for launch in fiscal 2025 with the goals of reducing the psychological burden of working people in customer service roles and contributing to the creation of safe and supportive work environments.BackgroundCustomer harassment has become a serious social issue. A recent survey revealed that 46.8% of service industry workers have encountered customer harassment in the past two years, with nearly half experiencing lasting physical and mental health consequences.In response, the Ministry of Health, Labour and Welfare added mental health issues related to customer harassment to its work-related injury recognition criteria in September 2023. Furthermore, the Tokyo Metropolitan Assembly passed Japan's first customer harassment prevention ordinance in October 2024. The growing national and local government efforts are driving increased organizational responsibility for employee protection.Field Trial PeriodDecember 3, 2024 to March 31, 2025Figure 1: Overview diagram of the field trial Comment from Akiko Yamada, Head of the Converging Technologies Laboratory of Fujitsu Research, Fujitsu Limited:We have been pursuing research in converging technologies, combining cutting-edge digital technology with knowledge from humanities and social sciences to solve various social issues. This new initiative combines generative AI, behavioral change support technology, criminal psychology, and mental health expertise to tackle the significant social problem of customer harassment and secure the well-being of working people.Comment from Prof. Masayuki Kiriu, Dean, Faculty of Sociology, Toyo University:By incorporating psychological scales and stress measurement indicators into the "AI Tool for Experiencing Customer Aggression”, we expect to create a practical and effective customer harassment response training program for customer service personnel. This will significantly contribute to solving current customer harassment issues. We anticipate the emergence of new social contributions through converging technology in this pilot program.Comment from Kyoko Shimada, Representative Director, Kokoro Balance Research Institute:Customer harassment can inflict deep emotional wounds on employees. While eradication may be impossible, we can reduce its impact through organizational efforts. This research aims to strengthen organizations by focusing on employee mental health and response capabilities. By using globally recognized psychological scales and effective evaluation criteria, we aim to make this program scientifically sound, useful, and applicable for employees.About FujitsuFujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers in over 100 countries, our 124,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: Computing, Networks, AI, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.7 trillion yen (US$26 billion) for the fiscal year ended March 31, 2024 and remains the top digital services company in Japan by market share. Find out more: www.fujitsu.com.Press Contacts:Fujitsu LimitedPublic and Investor Relations DivisionInquiriesToyo UniversityToyo University General Affairs Department, Public Relations DivisionPhone: 03-3945-7571Reception hours: 9:00-18:00 JST (excluding Saturdays, Sundays, holidays, and university-designated holidays)E-mail: mlkoho@toyo.jpKokoro Balance Research InstituteE-mail: info@kokorobalance.jp Copyright 2024 JCN Newswire via SeaPRwire.com.

FxPro Group Announces the Launch of BankPro: A Private Digital Banking Solution

Nassau, the Bahamas , Dec 11, 2024 - (ACN Newswire via SeaPRwire.com) - FxPro Group, a global leader in financial services and trading, has launched BankPro, a cutting-edge Private Digital Bank designed to redefine digital financial solutions for individuals and corporations. BankPro combines private banking services with advanced investment and trading capabilities, offering clients a seamless, all-in-one application tailored to their financial needs.The launch of BankPro underscores FxPro Group's commitment to innovation and excellence, leveraging its 25 years of expertise and $120 million in Tier 1 company capital to introduce a next-generation digital banking solution. BankPro is regulated by the Central Bank of The Bahamas and operates with the highest standards of security and compliance.Key Features of BankPro:Multi-Currency AccountsBankPro provides access to over 24 currencies, enabling effortless international transactions at competitive exchange rates. Clients can manage their finances globally with a single account designed for both personal and corporate use.Visa Platinum CardsClients can access exclusive Visa Platinum cards, offering customizable spending limits, global acceptance, and enhanced security. Additionally, instant virtual cards provide a secure and efficient solution for online transactions, making BankPro a versatile option for all financial activities.Global Banking with Flat FeesBankPro simplifies international banking with flat-fee structures, ensuring transparent and predictable costs. This approach is particularly advantageous for high-value transactions, providing clarity and value for clients engaged in global business and personal finance.Comprehensive Investment and Trading PlatformBankPro integrates investment and trading capabilities, allowing clients to manage and grow their portfolios within the same platform. Key features include:Investing in over 2,100 Stocks and ETFs: Clients gain access to major exchanges, including NYSE, Nasdaq, LSE, XETRA, and Euronext.Real-Time Market Data: Active subscriptions include free live pricing from Nasdaq and LSE.Through FxPro Global Markets Ltd., clients can also trade over 200 Derivatives across Forex, Commodities, Metals, Indices, Stocks, and ETFs, enabling portfolio diversification and risk management.Corporate Banking SolutionsBankPro offers tailored services for businesses, including multi-currency accounts, streamlined expense management tools, and advanced treasury management solutions. Corporate clients benefit from high-spending Visa Platinum cards, detailed reporting tools, and access to flexible investment options.A Strong Foundation in the BahamasBankPro operates from its state-of-the-art headquarters in Lyford Cay, Nassau. The facility reflects the company's commitment to The Bahamas as a central hub for its operations. The company also has an office in the City of London, UK.As a fully regulated entity, BankPro prioritizes security and reliability, holding a professional membership with the Association of International Banks and Trust Companies.The company's regulatory foundation ensures robust protection for clients, complemented by advanced digital onboarding tools and fraud prevention measures. These features, combined with the FxPro Group's legacy of excellence, make BankPro a trusted partner for financial services.About FxPro GroupWith 25 years of experience, the FxPro Group is a global leader in financial services, offering trading solutions across Forex, Commodities, and more. With a presence in over 170 countries and $200+ million invested in elite sponsorships, FxPro has earned over 120 industry awards for its innovative technology and reliable services.The launch of BankPro marks the Group's expansion into digital private banking, combining its expertise in trading with cutting-edge financial solutions designed for the modern client. To know more please contact +1 242 603 2226.Media ContactBrand: BankPro LimitedContact: Media teamWebsite: https://www.bankpro.com Copyright 2024 ACN Newswire via SeaPRwire.com.

以色列对叙利亚发动“历史上最大规模之一”的袭击——媒体报道 “`

(SeaPRwire) -   据报道,战机袭击了该国250多个军事目标 据多家媒体报道,以色列对叙利亚目标发动了大规模袭击,战机在巴沙尔·阿萨德前政府垮台后猛烈攻击了至少三个机场和其他基础设施。据报道,以色列坦克已突破叙利亚边境的缓冲区,并向大马士革推进,但西耶路撒冷否认了这一说法。 一位不愿透露姓名的以色列安全消息人士告诉以色列军队电台,“叙利亚境内超过250个军事目标遭到袭击”,并将此次袭击描述为“…[以色列]空军历史上最大规模的攻击行动之一”。 目标包括“阿萨德军队的基地、数十架战斗机、数十个地对空导弹系统、生产基地和仓库……以及地对地导弹”。 《耶路撒冷邮报》援引叙利亚安全消息人士的话称,空袭的目标是位于土耳其边境的卡米什利空军基地、靠近黎巴嫩边境的辛沙尔基地以及大马士革西南部的亚喀巴机场。 据报道,其他袭击目标包括叙利亚首都周边的一个研究中心和一个电子战中心。Al Mayadeen还声称,以色列袭击了阿勒颇南部农村地区的国防工厂。 据几家当地媒体报道,以色列坦克已逼近叙利亚首都。然而,以色列军方否认了这一说法。一名国防官员告诉RT,“媒体关于以色列坦克据称向大马士革推进的报道是虚假的”,并补充说,“国防军部队驻扎在缓冲区内,正如过去所述”。 在以Hayat Tahrir-al-Sham (HTS)圣战组织为首的武装反对派对政府军发动突然袭击,导致阿萨德政府迅速垮台,前总统流亡俄罗斯后,以色列开始在叙利亚积极开展军事行动。 犹太国的军队开始控制根据1974年脱离接触协议建立的缓冲区,该缓冲区距离以色列占领的戈兰高地不远。以色列外交部长吉德翁·萨尔坚称,此次入侵是旨在确保安全的“临时措施”。 然而,总理本雅明·内塔尼亚胡表示,以色列打算永远控制自1967年六日战争以来一直非法占领的戈兰高地,“永远”,称该地区是他国家“不可分割的一部分”。 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。

马斯克回应泽连斯基关于北约的言论 “`

(SeaPRwire) -   美国当选总统的顾问似乎对此感到困惑 埃隆·马斯克对乌克兰总统泽连斯基关于向白宫施压要求基辅加入北约的言论表示困惑。 这位南非科技亿万富翁在美国总统大选上为唐纳德·特朗普的胜利发挥了重要作用,媒体称他为“第一好友”,因为他经常在特朗普的 Mar-a-Lago 住宅逗留。 周一,马斯克转发了他最喜欢的X创作者马里奥·纳夫瓦尔分享的一段视频,只加了一个“扬起的眉毛”的表情符号。这个符号代表“怀疑、疑问、不赞成、惊奇和困惑”。 马斯克是在回应纳夫瓦尔引用泽连斯基的话:“我将请求拜登邀请我加入北约……和特朗普谈论此事毫无意义。” 这段42秒的视频配有英文字幕,展示了泽连斯基在基辅向某人解释特朗普尚未入主白宫,乔·拜登仍在任。 “我将在不久的将来致电拜登总统,如果他有时间和我谈话,我会提出北约邀请的问题,因为他现在是美国总统,很多事情仍然取决于他的立场,”泽连斯基说。“在特朗普尚未入主白宫的时候,和他讨论这个问题毫无意义,这并不取决于他。” 马斯克为乌克兰提供了Starlink卫星通信服务,但他一直倡导与俄罗斯和平相处。特朗普曾邀请他担任新的政府效率部门(DOGE)咨询机构的领导人之一。 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。

中东国家谴责以色列入侵叙利亚

(SeaPRwire) -   卡塔尔外交部表示,以色列国防军越过戈兰高地推进是“对国际法的公然违反” 以色列对叙利亚的军事入侵受到了邻国埃及、约旦和卡塔尔的谴责,他们指责犹太国利用叙利亚总统巴沙尔·阿萨德被推翻的机会来夺取土地,违反了国际法。 在反对派势力占领大马士革和阿萨德逃往俄罗斯之后,以色列于周日将部队调入被占领的戈兰高地非军事缓冲区。以色列总理本雅明·内塔尼亚胡在该地区发表视频声明说,一旦叙利亚军队“放弃阵地”,以色列与叙利亚于1974年达成的建立非军事区的协议实际上已经“崩溃”。 以色列军队和坦克周一越过缓冲区,进入叙利亚境内,以色列国防部长以色列·卡茨表示,此次行动旨在创建一个新的“安全区域”,清除“重型战略武器和恐怖主义基础设施”。 此举受到了阿拉伯世界的批评。卡塔尔外交部称之为“危险的发展和对叙利亚主权和统一的公然攻击,以及对国际法的公然违反”。 约旦外交部长艾曼·萨法迪也发表了措辞相似的谴责声明,埃及外交部也发表了谴责声明,声明称以色列“利用……叙利亚的真空来占领更多叙利亚土地,并在违反国际法的情况下,在当地强加新的现实”。 以色列在1967年六日战争中从叙利亚手中夺取了戈兰高地,并于1981年单方面吞并了该地区。但是,根据1974年的部队分离协议,以色列和叙利亚同意在缓冲区部署联合国维和部队,该缓冲区直到周日才将戈兰高地被占领地区的以色列军队与叙利亚军队隔开。 随着以色列国防军(IDF)人员50年来首次越过缓冲区,以色列战机袭击了叙利亚境内的其他目标。被袭击的地点包括大马士革的梅泽军事基地和位于首都以南50公里的哈尔哈拉空军基地,以及南部城市达拉和苏韦达。 卡茨周一表示,他已经指示以色列国防军在“整个叙利亚”进行打击,以摧毁叙利亚军队的武器和基础设施。外交部长吉德翁·萨尔表示,这些袭击的目标是“战略武器系统,例如,剩余的化学武器,或远程导弹和火箭,以防止它们落入极端分子手中”。 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。

泽连斯基欲就北约成员国问题致电拜登 “`

(SeaPRwire) -   据报道,美国总统可能会在卸任前同意推进乌克兰的加入申请 弗拉基米尔·泽连斯基表示,他将致电美国总统乔·拜登,讨论乌克兰潜在加入北约的问题。此前,泽连斯基和美国当选总统唐纳德·特朗普周六在巴黎举行了会谈。 基辅长期以来一直渴望加入美国领导的军事集团,认为这是对抗俄罗斯的根本安全保障。然而,莫斯科表示,乌克兰加入北约的野心是2022年乌克兰冲突升级的关键原因之一。 “我很快就会打电话给拜登总统……并提出邀请加入北约的问题。他现在是美国现任总统,很多事情都取决于他的立场。在特朗普还没入主白宫之前,和他讨论这个问题毫无意义,”泽连斯基周一在其Telegram频道上写道。 《华尔街日报》上周报道称,特朗普的团队对向乌克兰提供北约成员资格几乎没有兴趣,同时支持现任政府在拜登任期于下个月结束前加快向乌克兰运送武器的举动。 拜登迄今为止一直抵制基辅的要求,称乌克兰还没有准备好加入该集团。然而,《金融时报》10月份报道称,有“初步迹象”表明,美国总统可能会在1月份卸任前同意推进乌克兰加入北约的申请。 乌克兰坚称,加入北约是该国“唯一真正的安全保障”,基辅不会接受“任何替代方案、替代品或替代物”来代替正式成员资格。 周日,在法国与乌克兰领导人会晤后,特朗普呼吁立即停火,并开始基辅和莫斯科之间的谈判。当选总统在社交媒体上发帖称,“中国可以提供帮助”,指的是北京正在进行的调解努力。 莫斯科坚持认为,必须实现其军事行动的目标——包括乌克兰保持中立,以及“去军事化和去纳粹化”——才能解决冲突。 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。

以色列称已袭击叙利亚境内的化学武器设施

(SeaPRwire) -   西耶路撒冷表示,在巴沙尔·阿萨德下台后,它希望阻止此类武器落入敌对势力手中 据以色列外交部长吉德翁·萨尔称,以色列国防军 (IDF) 发动空袭,目标是叙利亚境内的疑似化学武器设施和远程导弹设施。萨尔周一告诉记者,西耶路撒冷的目标是防止所谓的武器储备落入敌对组织手中。 “我们唯一的兴趣是以色列及其公民的安全,”他说道。 虽然没有透露袭击的具体时间和地点,但美联社记者报道称,周日在大马士革西南部的梅泽军事机场附近发生了空袭。该设施一直是以色列空袭的常见目标,尽管目前尚不清楚最新袭击的责任方是谁。 近年来,以色列在叙利亚进行了数百次空袭,目标是其所说的与真主党武装组织相关的军事设施。周一,以色列国防部长以色列·卡茨表示,已下令军队完全控制叙利亚边境沿线的戈兰高地缓冲区(非法占领地区)。 他强调了阻止从伊朗向黎巴嫩走私武器的计划,并继续打击“战略武器”,例如导弹和防空系统,以确保它们不会落入敌对势力手中。 周末,武装反对派迅速控制了大马士革。与此同时,俄罗斯外交部证实,在与反对派谈判后,巴沙尔·阿萨德辞去总统职务并前往莫斯科。 自2011年叙利亚内战爆发以来,美国、英国和其他西方国家一直指责前总统巴沙尔·阿萨德政府对平民和反对派使用化学武器,并以此为由,自2014年以来,美国军队一直占领叙利亚东北部石油丰富的地区。 2018年,在“白头盔”非政府组织声称阿萨德军队在杜马使用化学武器后,美国、英国和法国对叙利亚政府设施发动了导弹袭击。叙利亚政府否认参与其中,大马士革和莫斯科都声称证据表明袭击是精心策划的。 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。